Covid-19 Pandemisi Sırasında Kadınların Kontraseptif Yöntem Kullanım Değişimlerinin ve Memnuniyetlerinin Değerlendirilmesi

Amaç: Coronavirüs hastalığı, küresel bir salgın olmasının yanı sıra, özellikle aile planlaması hizmetlerinde ve sağlık sisteminde bazı aksaklıklar yaratmaktadır. Çalışmamız, üniversite hastanemize başvuran kadın hastaların kontraseptif yöntem tercihlerini, memnuniyet düzeylerini ve pandemi nedeniyle yöntem kullanımlarının değişip değişmediğini değerlendirmeyi amaçlamıştır.

Anahtar Kelimeler:

COVID-19, üreme sağlığı, Kontrasepsiyon, Kontraseptif yöntem seçimi

EVALUATION OF CONTRACEPTIVE METHOD USAGE CHANGES AND SATISFACTION OF WOMEN DURING THE COVID-19 PANDEMIC

Objective: In addition to being a global epidemic, Coronavirus disease creates some disruptions in the health system, especially in family planning services. Our study aimed to assess the contraceptive method preferences of female patients who applied to our university hospital, their satisfaction levels, and whether their method usage had changed due to the pandemic.

Keywords:

contraception, choice of contraceptive methods, COVID-19, reproductive health,

PDF

___

1. Cevik M, Bamford C, Ho A. COVID-19 pandemic–a focused review for clinicians. Clin Microbiol Infect. 2020;26(7):842-7.
2. World Health Organization (WHO). Accessed date: 1 April 2021: http://www.who.int.
3. World do meters. Accessed date: 20 April 2021: https://www.worldometers.info/coronavirus.
4. Lafrenière J, Sweetman C, Thylin T. Introduction: gender, humanitarian action and crisis response. Gender & Development. 2019;27(2):187-201.
5. Uçar M, Demirbaş O, Aslan R, Kutlu R, Sayın S. Kadınların sosyodemografik özelliklerine göre kontraseptif yöntem kullanma durumları ve bu yöntemleri tercih nedenleri. Türkiye Aile Hekim Derg. 2014;18(3):134-41.
6. Çolgar U. Reprodüktif Endokrinoloji ve İnfertilite. 2nd ed. İstanbul. İstanbul Medikal Yayıncılık, 2006.
7. Hussein J. COVID-19: What implications for sexual and reproductive health and rights globally? Sex Reprod Health Matters. 2020;28(1):1746065.
8. Sacco MA, Caputo F, Ricci P, Sicilia F, De Aloe L, Bonetta CF et al. The impact of the Covid-19 pandemic on domestic violence: The dark side of home isolation during quarantine. Med Leg J. 2020;88(2):71-3.
9. Taşkın L. Doğum ve Kadın Sağlığı Hemşireliği. 6. baskı. Ankara. Ankara Sist Ofset Matbaacılık, 2003.
10. Johnson S, Pion C, Jennings V. Current methods and attitudes of women towards contraception in Europe and America. Reprod Health. 2013;10:7.
11. Sağsöz N, Bayram M, Kamacı M. Kırıkkale ili ve çevresinde kullanılan kontraseptif yöntemler. Türkiye Klin J Gynecol Obs. 2000;10(4):266-9.
12. Sektörler Arası Çocuk Kurulu. Türkiye Nüfus ve Sağlık Araştırması Raporu 2018. Accessed date: 1 April 2021: https://www.sck.gov.tr/wp-content/uploads/2020/08/TNSA2018_ana_Rapor.pdf.
13. Lete I. Combined hormonal contraception and COVID-19. Eur J Contracept Reprod Health Care. 2021;26(2):128-31.
14. Flumignan RLG, de Sá Tinôco JD, Pascoal PIF, Areias LL, Cossi MS, Fernandes MICD et al. Prophylactic anticoagulants for people hospitalised with COVID‐19. Cochrane Database Syst Rev. 2020;10(10):CD013739.
15. Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8.
16. Lete I, Chabbert-Buffet N, Jamin C, Lello S, Lobo P, Nappi RE et al. Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review. Eur J Contracept Reprod Heal Care. 2015;20(5):329-43.
17. Ferreira-Filho ES, de Melo NR, Sorpreso ICE, Bahamondes L, Simões RDS, Soares-Júnior JM et al. Contraception and reproductive planning during the COVID-19 pandemic. Expert Rev Clin Pharmacol. 2020;13(6):615-22.
18. Wood SN, Karp C, OlaOlorun F, Pierre AZ, Guiella G, Gichangi P et al. Need for and use of contraception by women before and during COVID-19 in four sub-Saharan African geographies: results from population-based national or regional cohort surveys. Lancet Glob Health. 2021;9(6):e793-e801.
19. Townsend JW, Ten Hoope-Bender P, Sheffield J; FIGO Contraception and Family Planning Committee. In the response to COVID-19, we can't forget health system commitments to contraception and family planning. Int J Gynaecol Obstet. 2020;150(3):273-4.